SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Zoracles

A sharp, high-volume rally has drawn attention to ZORA, with traders attributing the move to low liquidity and potential short-squeeze dynamics. The community is split between expecting further momentum from its creator/attention-market ecosystem and warning that the move could be another speculative pump-and-dump, with Bitcoins broader trend also cited as a key influence.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Attention is centered on reports that Michael Burry increased his long position in Lululemon, reinforcing a contrarian value narrative ahead of earnings. Bulls are also speculating that tariff refunds could lift results and trigger short covering, while bears remain focused on weak consumer demand, competition, tariffs, and potential guidance risk.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

Continued reports of tanker attacks and severely disrupted shipping through the Strait of Hormuz are driving USO attention, with traders split between a potential supply shock and claims that alternative routes or a reopening could ease crude prices. The Venezuela oil agreement adds a competing long-term supply narrative, though many traders argue its heavy crude and infrastructure needs limit any near-term impact.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apples announced September 9 product event and John Ternuss transition to CEO are driving attention, with traders focusing on a potential foldable iPhone and upgraded Siri AI. Bulls expect a pre-event run-up, while skeptics cite valuation, memory costs, softer services growth, and possible sell-the-news weakness.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Community-led expansion of Kendus IRL brandincluding products, events, businesses, and other initiativesis the dominant focus, with traders framing the ongoing activity and token accumulation as evidence of project strength. Sentiment is overwhelmingly bullish, though claims of an imminent major surge remain speculative.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

A hawkish Jackson Hole message from Fed Chair Kevin Warsh, alongside firm inflation data and higher rate expectations, triggered a sharp gold and GLD selloff as the dollar and Treasury yields strengthened. Traders remain divided between expecting further technical downside and viewing the pullback as a buying opportunity, with longer-term bulls citing fiscal deficits, Treasury intervention and currency-debasement concerns.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Reports that SK hynix is considering Intel Foundry for future HBM base-die production have fueled speculation about a major new customer and revived Intels foundry turnaround narrative. Traders are broadly bullish on the potential deal, though some note it remains unconfirmed and frame the move as a buy the rumor, sell the news setup amid ongoing concerns about foundry losses and semiconductor-sector volatility.

Helium is a decentralized machine network powered by a physical blockchain. The network is created by gateways who also double as miners on our network. These gateway operators can earn tokens based on coverage they provide as well as transaction fees gained from machines connecting to their gateway  Helium is a new cryptocurrency. Hotspots earn for providing and validating wireless coverage and when devices on the network connect to the internet through Hospots  Helium is mined and distributed to Hotspot Owners, Helium Inc, and investors. There is no pre-mine of Helium, and every month approximately 5,000,000 new Helium are minted.  At the end of each mining period, roughly every 30 to 60 mins, Helium is distributed according to the allocation shown:

Helium

Celina, Texass reported conversion of existing city Wi-Fi into Helium carrier coverage is driving attention, with traders viewing it as evidence of real-world DePIN and mobile adoption that could expand to other municipalities. Debate centers on whether network usage, carrier offload, and token burns can offset concerns about HNT dilution, weak hotspot economics, and a potentially speculative pump.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Attention is centered on SELLASs pivotal REGAL AML trial, which remains at 78 of 80 required events before final efficacy analysis and topline data. Traders are split between bullish speculation that the prolonged event timeline and supportive pharmaceutical-industry comments signal durable GPS benefit, and bearish concerns about trial design, censoring, control-arm survival, and the binary risk of a disappointing readout.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet is drawing attention for a technical rebound within a prolonged, range-bound stretch, with traders divided between a breakout thesis and expectations of renewed weakness. The broader debate centers on Alphabets AI opportunityparticularly TPUs, Cloud and Geminiversus heavy infrastructure spending, uncertain returns and regulatory pressure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SLS $MRK $BMY $JNJ 

Let the three giants fight it out to see who writes the biggest upfront cash/stock check for a total oncology monopoly. This is a textbook bidding collision. 

🔥Look at the corporate battle lines:

1. BMS: Must defensively protect its AML maintenance crown (Onureg) from JNJ&#39;s threatening Phase 3 cAMeLot-2 trials. Buying Sellas blocks JNJ and secures their monopoly.

2. JNJ: Slashed early R&amp;D by 42%. Their lead asset bleximenib is stuck in a narrow 15% mutation niche. They must buy Sellas’s universal WT1 platform to capture the other 85% of AML patients.

3. Merck: Pipelines are dangerously top-heavy after Phase 1 starts tripled. Facing a massive patent cliff, they desperately need advanced Phase 3 anchors like GPS to pair with Keytruda and extend their oncology dominance. 🧬🚀

upgrador

Christy Morgan

Dan flint

Andy L.

Penny Less

Shannon Chenery

Stephen

Bryan Farr

Thor

@Juhanialainen @Duncan74 Merck is the one to eat all !

StockTwits Web

Paul Nipkow

StockTwits for iOS

Merck & Co Inc

Bristol-Myers Squibb Co.

Johnson & Johnson

Speculation that Johnson & Johnson could acquire Sellas Life Sciences oncology assets is generating significant attention, though no deal has been confirmed. Traders are also highlighting JNJs strong uptrend, new highs and broader rotation into defensive healthcare stocks, with some viewing the proposed talc settlement as reducing a major legal overhang.

 

Let the three giants fight it out to see who writes the biggest upfront cash/stock check for a total oncology monopoly. This is a textbook bidding collision. 

🔥Look at the corporate battle lines:

1. BMS: Must defensively protect its AML maintenance crown (Onureg) from JNJ's threatening Phase 3 cAMeLot-2 trials. Buying Sellas blocks JNJ and secures their monopoly.

2. JNJ: Slashed early R&D by 42%. Their lead asset bleximenib is stuck in a narrow 15% mutation niche. They must buy Sellas’s universal WT1 platform to capture the other 85% of AML patients.

3. Merck: Pipelines are dangerously top-heavy after Phase 1 starts tripled. Facing a massive patent cliff, they desperately need advanced Phase 3 anchors like GPS to pair with Keytruda and extend their oncology dominance. 🧬🚀